Navigation Links
International Society for Stem Cell Research Highlights New YouTube Channel Providing Accurate Scientific Perspectives on Stem Cell Research
Date:10/30/2008

The International Society for Stem Cell Research (ISSCR) commends the recent launch of a YouTube channel created by the University of Michigan and designed to share advances in stem cell science. The channel comes during a heightened period of interest concerning stem cell research in Michigan: On Tuesday, voters will be asked to support Michigan's Proposal 2, a state initiative to accelerate medical research and develop new stem cell treatments for currently incurable diseases.

Deerfield, IL (PRWEB) October 30, 2008 -- The University of Michigan launched a new channel on YouTube.com this week to highlight and share advances in stem cell science. This educational effort is supported by the University's stem cell research programs and commended by the International Society for Stem Cell Research (ISSCR).    

With additional stem cell research and trials, stem cells have the potential to improve the lives of millions of patients suffering from a wide range of conditions and diseases, including Parkinson's, diabetes and spinal cord injury. The University of Michigan has an extensive stem cell research program led by the Center for Stem Cell Biology and members of the ISSCR.

University researchers created the YouTube channel to communicate facts about stem cell research and to address misunderstandings that surround research, especially embryonic stem cell research. The videos connect viewers to the researchers behind the science. Researchers share the intricacies of their work, including where stem cells come from, how the cells function and the importance of ethical protections and support for research efforts.

The timing of this channel comes during a heightened period of interest concerning stem cell research in Michigan. On Tuesday, voters will be asked to support Michigan's Proposal 2, a state initiative to accelerate medical research and develop new stem cell treatments for currently incurable diseases.

The ISSCR encourages patients, future patients, friends and family to visit the YouTube site to learn more about stem cell research.

The International Society for Stem Cell Research (ISSCR) is an independent, nonprofit membership organization established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell research and application.

###

Read the full story at http://www.prweb.com/releases/stem-cell-research/102008/prweb1550404.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. WellPoint Awarded Prestigious International Marketing Award
2. Lifeclinic International Has Named John T. Kelly, M.D., Ph.D. Chief Medical Officer
3. Shengtai Pharmaceutical Expands International Sales Program
4. Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy
5. Susan G. Komen for the Cure(R) Strengthens Global Mission With Addition of Vice President, International
6. PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
7. New Program Internationalizes Health and Fitness Research
8. uKarma Reports Progress With International Distribution Agreement for Its Xflowsion DVD Series
9. Animal Health International, Inc. Announces Its First Quarter Fiscal Year 2009 Earnings Release Date and Conference Call Information
10. FGX International to Release Third Quarter Earnings
11. CHADD to Host International Conference on AD/HD in Anaheim, CA; Olympian Bruce Jenner to Keynote
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
International Society for Stem Cell Research Highlights New YouTube Channel Providing Accurate Scientific Perspectives on Stem Cell Research 
(Date:2/21/2017)... ... , ... Doctors on Liens has announced the addition of Mendonca Spine ... its growing network of doctors in Central and Northern California. Dr. Mendonca specializes in ... whiplash, back pain, neck pain, hip and knee pain, and headaches. Specializing in ...
(Date:2/21/2017)... ... 2017 , ... Individuals who have been diagnosed with cancer ... therapy and management. Regular exercise in proper environments has been shown to benefit ... On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx webinar ...
(Date:2/21/2017)... , ... February 21, 2017 , ... Support of value-based ... simplify the secure exchange of data across industry solutions, Fogo Data Centers announces the ... of community. A healthy community is one in which all systems work well, ...
(Date:2/21/2017)... ... February 21, 2017 , ... Bioclinica®, ... expansion of its eHealth App xChangeâ„¢, providing clinical researchers more choices in ... and growing eHealth platform. Applications that enable patient-centered clinical trials make up ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... YORK , Feb. 21, 2017 ... industry. This technique is allowing a previously unattainable ... simplicity. Due to this ability, it is anticipated ... cross US$ 4 Billion by 2022. The growth ... by advancements in computing platforms, rising installation of ...
(Date:2/21/2017)... -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in ... release its fourth quarter and full year 2016 financial ... 2017. The press release will be followed by a ... open to the public via telephone and webcast. During ... results and provide a business update. The ...
(Date:2/21/2017)... FALLS, Idaho , Feb. 21, 2017  International ... has completed a private placement with certain investors for ... stock of the Company, Series C Convertible Redeemable Preferred ... accrues dividends at an annual rate of 6% and ... The Company plans to use the proceeds for operating ...
Breaking Medicine Technology: